USE OF TRANSFERRIN RECEPTOR ANTAGONIST FOR THE TREATMENT OF THALASSEMIA

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150197574A1
SERIAL NO

14418457

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present disclosure relates to antagonists of transferrin receptor and compositions and methods of use of said antagonists for treating pathological disorders such as thalassemia disorders

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)3 RUE MICHEL ANGE PARIS 75016
UNIVERSITE PARIS-SUD XI15 RUE GEORGES CLÉMENCEAU ORSAY CEDEX 91405
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)101 RUE DE TOLBIAC PARIS 75013
UNIVERSITE PARIS DIDEROT - PARIS 75 RUE THOMAS MANN PARIS 75013
UNIVERSITE PARIS DESCARTES12 RUE DE L'ECOLE DE MÉDECINE PARIS 75006
ASSISTANCE PUBLIQUE-HOPITAUX DE PARIS (APHP)3 AVENUE VICTORIA PA 75004
FONDATION IMAGINE24 BOULEVARD DU MONTPARNASSE PARIS 75015

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cruz-Moura, Ivan Paris, FR 3 2
Dussiot, Michael Paris, FR 7 92
Hermine, Olivier Paris, FR 35 115
Paubelle, Etienne Paris, FR 2 2
Trovati, Maciel Thiago Paris, FR 8 92

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation